Tranexamic acid in primary CABG surgery: High vs low dose;Impiego dell'acido tranexamico negli interventi di rivascolarizzazione coronarica: Confronto fra basso e alto dosaggio

Minerva Anestesiologica

Volumn 70, Issue 3, 2004, Pages 97-107

  Armillin, G ^a   Vinciguerra, A ^a   Bonato, R ^a   Pittarelo, D ^a   Giron, G P ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Anesthesia; Antifibrinolytic agents; Blood transfusion, autologous; Cardiopulmonary bypass; Tranexamic acid

Indexed keywords

APROTININ; EPSOCLAR 25000; HEPARIN; PLACEBO; PROTAMINE; TRANEXAMIC ACID;

AGED; ANESTHESIA INDUCTION; ARTICLE; BLOOD CLOTTING; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EXCRETION; DRUG HALF LIFE; DRUG INFUSION; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; ELECTIVE SURGERY; FEMALE; HEART MUSCLE REVASCULARIZATION; HEPARINIZATION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; SURGICAL TECHNIQUE; THROMBOEMBOLISM; THROMBOGENESIS;

AGED; ANTIFIBRINOLYTIC AGENTS; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; TRANEXAMIC ACID;

EID: 3142769923     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Karski JM, Teasdale SJ, Norman P, Carroll J, VanKessel K, Wong P et al. Prevention of bleeding after cardiopulmonary bypass with high dose tranexamic acid. J Thorac Cardiovasc Surg 1995; 110: 835-42.
2. Speekenbrink RGH, Vonk ABA, Wildevuur CRH, Eijsman L. Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting. Ann Thorac Surg 1995; 59: 438-42.
3. Casati V, Guzzon D, Oppizzi M, Cossolini M, Torri G, Calori G et al. Hemostatic effects of aprotinin, tranexamic acid and epsilon-aminocaproic acid in primary cardiac surgery. Ann Thorac Surg 1999;68:2252-6.
4. Horrow JC, Hlavacek J, Strong MD, Collier W, Brodsky I, Goldman SM et al. Prophylactic tranexamic acid decreases bleeding after cardiac operations. J Thorac Cardiovasc Surg 1990;99:70-4.
5. Pleym H, Stenseth R, Wahba A, Bjella L, Karevold A, Dale O. Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery. Anesth Analg 2003;96: 923-8.
6. Katsaros D, Petricevic M, Snow NJ, Woodhall DD, Van Bergen. Tranexamic acid reduces postbypass blood use: a double blinded, prospective, randomized study of 210 patients. Ann Thorac Surg 1996;61:1131-5.
7. Pugh SC, Wielogorski AK. A comparison of the effects of tranexamic acid and low-dose aprotinin on blood loss and homologous blood usage in patients under-going cardiac surgery. J Cardiothorac Vasc Anesth 1995; 9:240-4.
8. Rousou JA, Engelman RM, Flack JE, Deaton DW, Owen SG. Tranexamic acid significantly reduces blood loss associated with coronary revascularization. Ann Thorac Surg 1995;59:671-5.
9. Brown RS, Thwaites BK, Mongan PD. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: a double blind, randomized, placebo-controlled trial. Anesth Analg 1997;85:963-70.
10. Mongan PD, Brown RS, Thwaites BK. Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization. Anesth Analg 1998;87:258-65.
11. Rubens F, Wells P. Tranexamic acid use during coronary artery bypass grafting. Ann Thorac Surg 1996;61:774-5.
12. Karski JM, Dowd NP, Joiner R, Carroll J, Peniston C, Bailey K et al. The effect of three different doses of tranexamic acid on blood loss after cardiac surgery with mild systemic hypothermia (32°). J Cardiothorac Vasc Anesth 1998;12:642-6.
13. Horrow JC, Van Riper DF, Strong MD, Grunewald KE, Parmet JL. The dose-response relationship of traneximic acid. Anesthesiology 1995;82:383-92.
14. Wong BI, McLean RF, Fremes SE, Deemar KA, Harrington EM, Christakis GT et al. Aprotinin and tranexamic acid for high transfusion risk cardiac surgery. Ann Thorac Surg 2000;69:808-16.
15. Hardy Jf, Bélisle S. Natural and synthetic antifibrinolytics: inert, poisonous or therapeutic agents? Can J Anaesth 1997;44:913-7.
16. Unsworth-White MJ, Herriot A, Valencia O, Poloniecki J, Smith EE, Murday AJ et al. Resternotomy for bleeding after cardiac operation: a marker for increased morbidity and mortality. Ann Thorac Surg 1995;59:664-7.
17. Michalopoulos A, Tzelepis G, Dafni U, Geroulanos S. Determinants of hospital mortality after coronary artery bypass grafting. Chest 1999;115:1598-603.
18. Lambert W, Brisebois FJ, Wharton TJ, Carrier RC, Boyle D, Rowe BH. The effectiveness of low dose tranexamic acid in primary cardiac surgery. Can J Anaesth 1998;45:571-4.
19. Casati V, Guzzon D, Oppizzi M, Bellotti F, Franco A, Gerli C et al. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions. J Thorac Cardiovasc Surg 2000;120:520-7.
20. CJ Dunn, KL Goa. Tranexamic acid: a review ot its use in surgery and other indications. Drugs 1999;57: 1005-32.
21. Øvrum E, Holen EA, Abdelnoor M, Øystese R, Lindstein Ringdal M. Tranexamic acid (Cyclokapron) is not necessary to reduce blood loss after coronary artery bypass operations. J Thorac Cardiovasc Surg 1993;105:78-83.
22. Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJM, Briët E et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999;354:1940-7.
23. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. Anesth Analg 1997;85:1258-67.
24. Karski J, Iwanochko M, Kucharczyk W, Seneviratne P, Carroll J, Liu P et al. Tranexamic acid and early graft patency in elective aortocoronary bypass (ACB) surgery. Can J Anaesth 1999;5:A29.
25. Alderman ER, Levy JH, Rich JB, Nili M, Vidne B, Schaff H et al. Analyses of coronary graft patency after aprotinin use: results from the international Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. J Thorac Cardiovasc Surg 1998;116:716-30.